Markets › India › NSE › WOCKPHARMA

Wockhardt Ltd

NSE:WOCKPHARMAHealthcareNSE:CNX500NSE:CNXPHARMA

₹1,906.30−2.49%At closeAt close · Mon 19 Oct · ≈ AED 73.65 · Market cap $3.33B

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	55.3%	58.2%	55.9%	56.5%	60.2%	38.2%	—	—
Operating margin	19.7%	30.6%	26.6%	29.5%	34.7%	11.9%	11.9%	+0.0 pts
Net margin	25.3%	−7.6%	−21.0%	−16.4%	−1.5%	6.3%	6.3%	+0.0 pts
EBITDA margin	−5.3%	7.0%	1.6%	4.9%	11.9%	20.1%	—	—
Return on equity	20.3%	−6.3%	−16.7%	−13.8%	−1.1%	4.3%	4.0%	−0.3 pts
Return on assets	8.8%	−3.0%	−7.3%	−6.1%	−0.6%	2.5%	2.5%	+0.0 pts
Return on capital employed	11.5%	19.6%	16.6%	17.2%	17.3%	5.8%	—	—
Debt / equity	0.8×	0.6×	0.7×	0.7×	0.5×	0.5×	0.4×	−6.5%
Debt / assets	34.4%	26.7%	28.4%	30.8%	24.8%	25.9%	—	—
Interest coverage	2.1×	3.3×	2.3×	2.7×	4.1×	1.9×	—	—
Current ratio	0.8×	0.8×	0.6×	0.8×	1.2×	1.6×	1.6×	+0.0%
Quick ratio	0.5×	0.6×	0.5×	0.6×	0.9×	1.1×	—	—
Cash ratio	0.1×	0.1×	0.0×	0.2×	0.1×	0.2×	0.2×	+0.0%
Asset turnover	0.3×	0.4×	0.3×	0.4×	0.4×	0.4×	—	—
Inventory turnover	1.5×	1.8×	1.8×	1.9×	1.7×	2.3×	—	—
Receivables turnover	2.9×	3.3×	3.3×	4.6×	4.6×	5.7×	—	—
Dividend payout	0.1%	−0.8%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.